Posts
$QCLS Photonics = Multi-Bagger Swing Potential: Solving AI Computing & Fundamentally Underpriced
Energy consumption of AI workloads is unsustainable at current demand, and demand is growing exponentially. Solutions are in the theoretical pipeline but Photonics appear to represent the only viable solution for future-proofing AI energy demands, and from what I can tell, $QCLS is the only micro in the space. The …
Another record quarter for High Tide inc
**Officinal PR :** [https://www.newswire.ca/news-releases/high-tide-reports-second-quarter-2026-financial-results-featuring-record-revenue-of-179-3mm-and-adjusted-ebitda-of-13-9mm-889092761.html](https://www.newswire.ca/news-releases/high-tide-reports-second-quarter-2026-financial-results-featuring-record-revenue-of-179-3mm-and-adjusted-ebitda-of-13-9mm-889092761.html) **Q2 FY2026: $179.3M revenue (+30% YoY, fastest growth in 11 quarters), record $13.9M Adjusted EBITDA (+73% YoY), positive net income and free cash flow, plus a $40M BMO credit agreement.** HITI is becoming the definition of non-stop execution and deserves more credit for this. Remexian's goal …
The Lounge
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
Looking strongly at COSM
Just bought a small 5000 share position at what looks like a solid low. They just started making real money and the CEO (we’ve heard this before!) says dilution is a last resort. The only insider trading in the last year plus has been aggressive buying by the CEO Grigorios …
Spero Therapeutics $SPRO
​ Anyone looking into Spero Therapeutics? Key indicators including test efficacy, regulatory reviews and financial investment - all seems promising. ​ **Clinical trial foundation and Regulatory:** ​ \- Overall success reached 58.5% for oral tebipenem HBr compared to 60.2% for the standard IV treatment and the drug was found to …
ContextLogic ($WISH) Has Reached A Tentative Settlement With Investors, Payout Info
During 2020, Wish benefited from a surge in online shopping as consumers spent more time at home. The company highlighted rapid growth in monthly active users (MAUs), active buyers, and revenue, helping it raise more than $1.1 billion in its December 2020 IPO. Investors later claimed that Wish's growth was …
DD: FDA-cleared wound care tech, international distribution, strict NDA “gorilla” partner, and 2M units/year capacity — why this looks seriously undervalued
https://preview.redd.it/v52sxmu75i7h1.png?width=1174&format=png&auto=webp&s=390456b23fe0e84aa735d846bd6a06e6b264cee8 I’ve been digging into **Clyra Medical,** and this is one of the c**leanest small-cap medtech setups I’ve seen in a while**. The combination of FDA clearance, real clinical presentation data, international distribution, and a major global partner still under strict NDA makes this feel like a story the market …
AI and data centers are making lithium a bigger story than EVs alone
$LIB Leveraging oil&gas infrastructure to extract lithium. Now officially producing commercially. Being part of a comoany while moving from venture to producer can be very valueable. First off take agreement will take place in the coming weeks. They approach Lithium mining in a way saving years of construction and ramp …
Public debut of integrated autonomy ecosystem looks awesome!
I have been looking at some Nasdaq updates and I found out about VisionWave Holdings. They are starting to show their products to the public at Eurosatory 2026 in Paris today. they're also showcasing the things they make like the Varan ground vehicle and the technology they use for defense …
💎 What stands out about $LBRG? ◈ Dedicated acquisitions team ◈ Active M&A relationship building ◈ Focus on long-term shareholder returns ◈ Revenue-generating targets The foundation appears centered on disciplined expansion rather than speculative growth alone.
💎 What stands out about $LBRG? ​ ◈ Dedicated acquisitions team ◈ Active M&A relationship building ◈ Focus on long-term shareholder returns ◈ Revenue-generating targets ​ The foundation appears centered on disciplined expansion rather than speculative growth alone. ​ \#LBRG #ShareholderValue #Mergers #GrowthInvesting #MicroCap ​